pharma-manufacturer
FAQ's
Answer : Precedence Research announced, the global clinical trials market size was valued at USD 48.4 billion in 2020 and is expected to reach USD 84.43 billion by 2030.
Answer : The global clinical trials market is growing at a impressive CAGR of 5.7% during the forecast period 2022 to 2030.
Answer : Factors such as growing prevalence of chronic disorders, increasing number of clinical trials in developing regions, growing number of biologics, increasing demand for advanced treatments such as personalized medicines, outbreak of viral diseases, increasing cases of cancer globally, growing geriatric population and growing research and development expenditure are propelling the clinical trials market expansion across the globe.
Answer : The major companies operating in the worldwide clinical trials market are Parexel, IQVIA, Charles River Laboratory, Omnicare, Kendle, Chiltern, and Pharmaceutical Product Development, LLC. among others.
Answer : Interventional Study is projected to dominate the study design segment of clinical trials market revenue.
Answer : Constant research on cancer treatment and increasing demand for precision medicine are the major reasons responsible for high market share of oncology.?
Answer : Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing investment by governments in research and growing awareness regarding precision medicine.
Answer : Clinical Trials are a type of clinical research that are performed in people and are intended at assessing a behavioral, surgical, or medical intervention. Clinical Trials act as the prime way employed by the scientists to investigate if a new therapy, a medical device or anovel drug is secure and efficient in individuals.
Get a Sample of this Report
pharma-manufacturer
